Diabetic ketoacidosis protocol stopping criteria in children

Reading Document

Medical Text Search

diabetic ketoacidosis DKA stopping criteria resolution children pediatric

Medical Text Search

pediatric DKA insulin infusion transition subcutaneous criteria

GradeResponse

Medical Text Search

DKA resolution criteria pH bicarbonate glucose ketones pediatric end of treatment

Here is a comprehensive summary of pediatric DKA stopping/resolution criteria, synthesized from retrieved sources and established clinical guidelines:

Pediatric DKA: Protocol Stopping Criteria

The DKA protocol (IV fluid resuscitation + continuous insulin infusion) is considered complete and the patient ready for transition when all three resolution criteria are met simultaneously.

Biochemical Resolution Criteria

Parameter	Resolution Threshold
Blood glucose	< 11–14 mmol/L (200–250 mg/dL)
Venous/arterial pH	≥ 7.30
Serum bicarbonate	≥ 15 mmol/L
Anion gap	Normalized (≤ 12 mEq/L)
Blood β-hydroxybutyrate (βOHB)	< 1.0 mmol/L (some guidelines use < 0.5–0.6 mmol/L)

Resolution of acidosis or reduction in blood βOHB is the traditional marker for successful DKA treatment. Serial urine ketone negativity alone is not a reliable stopping criterion, as acetoacetate and acetone may paradoxically increase while βOHB falls during effective therapy (Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus, p. 25).

Clinical Resolution Criteria

Child is alert and tolerating oral intake (eating and drinking without vomiting)
Haemodynamically stable, no ongoing clinical signs of severe dehydration
IV fluids no longer required to maintain hydration

Transition to Subcutaneous Insulin (Key Step)

The IV insulin infusion is not simply stopped — transition must be carefully timed:

Confirm biochemical + clinical resolution (criteria above)
Administer the first subcutaneous (SC) dose of insulin (rapid-acting or long-acting, depending on regimen)
Continue the IV insulin infusion for 30–60 minutes after the SC injection to allow subcutaneous absorption to begin (prevents rebound ketosis)
Then discontinue the IV infusion and IV fluids

One RCT in pediatrics found that subcutaneous insulin (0.15 U/kg every 2 hours) for mild-to-moderate DKA was safe, effective, and reduced cumulative insulin dose and length of stay compared to IV infusion (Glycemic Management Across the Lifespan for People With Type 1 Diabetes, p. 9).

Important Monitoring Notes

Use blood βOHB (point-of-care), not urine ketones, for monitoring resolution — urine ketones lag behind and can be misleading
βOHB < 0.5 mmol/L is the normal fasted reference; DKA is generally confirmed at > 2.0 mmol/L
Glucose normalizing before acidosis resolves is common — do not stop insulin; instead add dextrose to IV fluids to maintain glucose 8–12 mmol/L while continuing insulin to clear ketones
Watch for cerebral edema throughout treatment (most common serious complication in children), particularly in the first 4–12 hours

Summary Algorithm

Glucose falling → Add dextrose to IV fluid (keep glucose 8–12 mmol/L)
         ↓
ALL of: pH ≥ 7.30 + HCO₃ ≥ 15 + βOHB < 1.0 mmol/L
         ↓
Child tolerating oral intake?
         ↓ YES
Administer first SC insulin dose
         ↓
Wait 30–60 min
         ↓
Stop IV insulin infusion + IV fluids

Note: Specific numeric thresholds vary slightly across ISPAD (International Society for Pediatric and Adolescent Diabetes), BSPED (British Society for Paediatric Endocrinology), and local institutional protocols. Always defer to your local DKA pathway for exact cutoffs.

This is a shared conversation. Sign in to Orris to start your own chat.